Moxitop Eye Drops (Moxifloxacin Hydrochloride)
Moxifloxacin Hydrochloride
Prescription medication
COSMAX Pharma Co., Ltd.
MFDS item code 201900161 · Notified 2019.01.14
This product's status changed to Approval withdrawn on 2023.07.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of bacterial conjunctivitis, keratitis, and sterilization effect before and after ophthalmic surgery
This medication is used to treat bacterial conjunctivitis and keratitis (including corneal ulcers) caused by various bacteria such as Staphylococcus, Streptococcus, and Pneumococcus. It is also effective for maintaining a sterile condition before and after ophthalmic surgery. It is widely used in the treatment of eye infections targeting various gram-positive and gram-negative strains. This medication plays a crucial role in effectively treating infections of ophthalmic diseases and preventing post-surgical infections. It is used for the treatment of bacterial infections in ophthalmic diseases and for sterilization.
1. Bacterial conjunctivitis, keratitis (including corneal ulcers): Typically, instill 1 drop 3 times a day. The dosage may be adjusted according to symptoms. 2. Sterilization therapy before and after ophthalmic surgery: Typically, instill 1 drop 5 times a day before surgery and 1 drop 3 times a day after surgery.
This medication should not be injected directly into the conjunctiva or the anterior chamber of the eye. Serious allergic reactions may occur in patients receiving systemic quinolone medications containing the same component; therefore, administration should be discontinued immediately and emergency treatment sought if symptoms appear. It should not be used in patients with hypersensitivity to this medication or in infants under 1 year of age. Pregnant or nursing women should use it cautiously under a doctor's supervision. During use, adverse reactions such as eye congestion, pain, itching, or dryness may occur, and rarely, symptoms like systemic fever or cough have been reported. In the case of suspected allergic reactions or serious side effects, discontinue use immediately and consult with medical personnel. During the treatment of infections, it should be used for the minimum duration necessary to prevent the development of resistant bacteria, and caution is advised as prolonged use may lead to other infections. Patients with bacterial conjunctivitis are advised to avoid wearing contact lenses. This medication should be used only for ocular instillation, and care should be taken to prevent the opening of the container from contacting the eye, hands, or other sources of contamination. If used with other eye drops, they should be administered at least 5 minutes apart, and any unused medication should be discarded immediately after opening. Keep out of reach of children, and store in a cool place away from direct sunlight. There is insufficient data on the effects of this medication on fetuses or newborns when administered to pregnant or nursing women, hence it should be used cautiously. The safety for infants under 1 year has not been established, so it is preferable not to use it. Special caution is not required for the elderly, but they should immediately inform medical personnel if any adverse reactions occur.
Hives, severe swelling (including angioedema, swelling of the throat, larynx, and face), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe skin reactions, severe rash, blisters, skin peeling, pain in oral or eye membranes, shortness of breath, asthma attack, respiratory abnormalities with cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy throughout the body, sudden and severe headache.
Conjunctivitis, decreased vision, dry eyes, keratitis, eye discomfort, eye congestion, eye pain, itching, subconjunctival hemorrhage, tearing, fever, cough, infections, otitis media, pharyngitis, redness, rhinitis, eye pain, dysgeusia, abnormal sensation at the application site, atrial fibrillation, dizziness, endophthalmitis, ulcerative keratitis, corneal erosion, corneal abrasion, increased intraocular pressure, corneal opacity, corneal infiltrates, corneal deposits, allergy, corneal edema, glare, corneal abnormalities, eyelid
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 2 degrees and 25 degrees Celsius. By storing it this way, the effectiveness of the medication can be preserved safely.
A pale yellow-green ocular solution in a transparent plastic container
5mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Moxifloxacin Hydrochloride
Prescription medication
COSMAX Pharma Co., Ltd.

Moxifloxacin Hydrochloride 436.8mg
Tablet · Prescription medication
Bayer Korea Co., Ltd.
Moxifloxacin Hydrochloride 1.744mg
Injections · Prescription medication
Bayer Korea Co., Ltd.
Moxifloxacin Hydrochloride 5.45mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Moxifloxacin Hydrochloride 5.45mg
Eye drops · Prescription medication
Samchundang Pharmaceutical Co., Ltd.
Moxifloxacin Hydrochloride 5.45mg
Eye drops · Prescription medication
Samil Pharmaceutical Co., Ltd.
Moxifloxacin Hydrochloride 5.45mg
Eye drops · Prescription medication
Optus Pharmaceutical Co., Ltd.
Moxifloxacin Hydrochloride 5.45mg
Eye drops · Prescription medication
Hankook Hyutecs Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.